GET DAILY SIGNALSHealthcare Services Group (HCSG) Reports Solid Q3 Earnings and Raises 2027 Outlook
Key Takeaways
- Healthcare Services Group reported third-quarter 2026 revenue of $479.6 million, up about 3.3% from $464.3 million a year earlier.
- Diluted earnings per share (EPS) came in at $0.36, down from $0.59 in the prior-year quarter but well ahead of analyst expectations.
- The company completed its $93.5 million acquisition of NEXDINE Hospitality in October, adding an expected $150 million-plus in annual revenue.
- Management guided fourth-quarter revenue to $535 million to $545 million and raised its 2027 growth outlook to low double digits.
- Cost of services remained well below the company's 86% target at 83.2% of revenue, supported by strong execution and lower bad-debt expense.
- The company repurchased $11.7 million of stock in the quarter, bringing its year-to-date buyback total to $56.6 million.
Earnings Context and Why It Matters
Healthcare Services Group (HCSG) provides housekeeping, laundry, and dining services to healthcare, senior living, and campus facilities. Its quarterly results give insight into demand trends in the senior-care sector, where long-term demographic shifts are starting to take shape. This third-quarter update also arrives shortly after the close of the NEXDINE Hospitality acquisition, which expands the company's presence in senior living and hospitality markets. For investors, the report sheds light on organic growth, cost control, and capital allocation across acquisitions and share repurchases.
Reported Results
For the three months ended September 30, 2026, HCSG posted revenue of $479.6 million versus $464.3 million in the year-ago period. Environmental Services revenue reached $217.2 million with a 13.3% segment margin, while Dietary Services revenue was $262.4 million with an 8.7% segment margin. Cost of services came in at $399.2 million, or 83.2% of revenue, and SG&A expenses totaled $49.1 million, or 10.2% of revenue after adjusting for a $600,000 decline in deferred compensation. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Net income was $24.9 million, compared with $42.9 million a year earlier, and diluted EPS was $0.36 versus $0.59. The prior-year quarter included higher other income. The effective tax rate stood at 26.2%, with management expecting roughly 25% for the full year 2026. Even with the year-over-year drop, EPS comfortably beat consensus estimates near $0.22, helped by a $6.1 million recovery tied to the Genesis bankruptcy and bad-debt expense falling below 0.5% of revenue.
Market Reaction and Investor Sentiment
Before the release, attention focused on whether HCSG could maintain sequential revenue growth while keeping costs in check. The company delivered its ninth sequential revenue increase in the past ten quarters, and EPS significantly exceeded expectations, which should support sentiment. Shares had risen about 12.5% year-to-date heading into the announcement, roughly matching the broader market.
Post-release attention turned to the forward view. Management lifted 2027 revenue growth guidance from mid-single digits to low double digits and highlighted immediate accretion from NEXDINE Hospitality. Investors are also weighing risks such as variability in bad-debt expense, energy and supply cost swings, and the pace of acquisition integration.
Forward Outlook and Key Factors to Monitor
Management guided fourth-quarter 2026 revenue to $535 million–$545 million, incorporating both organic growth and the NEXDINE contribution, which is expected to add more than $150 million in annual revenue at margins similar to the core business. This implies a larger sequential revenue increase than the $8 million–$9 million steps seen in recent quarters.
Looking ahead, the 2027 revenue growth target was raised to low double digits from a prior mid-single-digit outlook. This rests on mid-single-digit organic growth, client retention above 90%, a solid new-business pipeline, and the aging U.S. population entering senior-care settings.
Several items warrant watching in coming quarters. Cost of services, targeted near 86% of revenue, will test operational discipline, as will SG&A, where the long-term aim is 8.5%–9.5% of revenue. The speed of NEXDINE integration and its margin impact, any further Genesis bankruptcy developments, the loss of interest income on acquisition funding, and payroll accrual timing (which affects fourth-quarter cash flow before reversing in early 2027) are all worth monitoring.
Using Tickeron’s AI Tools in My Research
When analyzing earnings like these, I find Tickeron’s AI Screener helpful for quickly comparing HCSG against peers on fundamentals, technical patterns, and recent performance. It lets me scan for similar opportunities in the sector without spending hours on manual filtering, which keeps my process efficient and data-driven.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
HCSG's Stochastic Oscillator dives into oversold zone
The Stochastic Oscillator for HCSG moved into oversold territory on November 13, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 10, 2026. You may want to consider a long position or call options on HCSG as a result. In 51 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
HCSG moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for HCSG crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 53%.
Following a +4.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where HCSG advanced for three days, in 198 of 290 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Aroon Indicator entered an Uptrend today. In 117 of 177 cases where HCSG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.
Bearish Trend Analysis
The 10-day RSI Indicator for HCSG moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In 24 of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.
The Moving Average Convergence Divergence Histogram (MACD) for HCSG turned negative on November 11, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 37 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HCSG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
HCSG broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. HCSG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 39 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.212) is normal, around the industry mean (204.532). P/E Ratio (14.035) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (1.359) is also within normal values, averaging (2.498). Dividend Yield (0.035) settles around the average of (0.154) among similar stocks. P/S Ratio (0.840) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 80 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HCSG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of housekeeping, laundry, linen, and facility maintenance services for the long-term health care industry
Industry HospitalNursingManagement
Advertisement